Oral minoxidil works by opening potassium channels in cells throughout the body, including those in hair follicles. This relaxes smooth muscle around blood vessels and follicles, increasing blood flow to the scalp and directly stimulating follicle activity. But the full picture involves an activation step inside the body, effects on the hair growth cycle, and some cardiovascular side effects that trace back to the same mechanism.
Potassium Channels and the Core Mechanism
Minoxidil belongs to a class of drugs called potassium channel openers. Specifically, it targets ATP-sensitive potassium channels (KATP channels) found in blood vessel walls and within hair follicles themselves. When minoxidil opens these channels, potassium ions flow out of cells, causing the cells to relax. In blood vessels, this means dilation and lower blood pressure, which is why minoxidil was originally developed as a blood pressure medication. In hair follicles, research shows these channels contain two types of regulatory components called sulfonylurea receptors (SUR1 and SUR2B), and minoxidil acts on both.
This isn’t just a blood flow story. When researchers blocked these potassium channels with specific inhibitors, minoxidil’s hair-stimulating effects disappeared completely. That confirms the drug is doing something directly inside the follicle, not simply improving circulation to the scalp.
Your Body Has to Activate It First
Minoxidil itself is actually a prodrug, meaning it doesn’t work in its original form. Your body must convert it into a compound called minoxidil sulfate before it can open those potassium channels and stimulate hair growth. This conversion happens through a group of enzymes called sulfotransferases, found in the liver, skin, and hair follicles.
At least four different sulfotransferase enzymes contribute to this conversion. When you take minoxidil orally, it passes through the liver first, where much of this activation occurs before the drug reaches your bloodstream and eventually your scalp. This is a key difference from topical minoxidil, which relies on sulfotransferase enzymes present locally in the skin and follicles. Some people naturally have lower sulfotransferase activity in their scalp, which may explain why topical minoxidil doesn’t work for everyone. The oral route partially bypasses this problem by using the liver’s enzymes to do the heavy lifting.
How It Changes the Hair Growth Cycle
Every hair follicle cycles through three phases: a growth phase (anagen), a transition phase (catagen), and a resting phase (telogen). In pattern hair loss, follicles spend less and less time in anagen, producing thinner, shorter hairs with each cycle until some follicles essentially go dormant.
Minoxidil reverses this in two ways. First, it extends the anagen phase, keeping follicles actively producing hair for longer. Animal studies show minoxidil delays the transition into catagen, and the mechanism appears to involve activation of a signaling pathway called beta-catenin in the specialized cells at the base of each follicle. Beta-catenin is one of the key molecular switches that tells a follicle to keep growing. Second, by prolonging anagen over multiple cycles, minoxidil allows miniaturized follicles to gradually produce thicker, more visible hairs.
This is also why results take time. Initial changes like reduced shedding typically emerge after 8 to 12 weeks. Visible regrowth usually appears between 3 and 6 months. Peak improvement in hair density can take 6 to 12 months of continuous use.
Oral vs. Topical: What the Data Shows
A meta-analysis comparing oral and topical minoxidil found no statistically significant difference in overall hair growth between the two. The odds ratio was 2.23 in favor of oral, but the result wasn’t significant (p = 0.11). One area where oral minoxidil did stand out was vertex (crown) density, where it performed about 24% better than topical in clinical measurements. Hair diameter was similar between the two groups.
The practical advantage of oral minoxidil is convenience. There’s no twice-daily scalp application, no greasy residue, and no concern about whether the drug is absorbing properly through your skin. For people who found topical minoxidil messy or ineffective, the oral form offers a simpler alternative with comparable results.
Typical Dosing
For hair loss, oral minoxidil is used at much lower doses than the original blood pressure indication. Women typically start at around 1 mg daily, while men may use doses up to 5 mg. A study comparing 1 mg oral minoxidil to 5% topical solution in women with pattern hair loss found similar results between the two. For men, 5 mg has been the most commonly studied dose.
Higher doses (above 5 mg) have been studied in a retrospective review of 57 patients. Most saw hair density improvements of 10 to 30%, with 17.5% of patients achieving greater than 50% improvement. Another 17.5% improved less than 10%, highlighting how variable the response can be from person to person.
Side Effects Trace Back to the Same Mechanism
Because oral minoxidil opens potassium channels throughout the body, not just in hair follicles, it comes with systemic effects that topical users rarely experience. The largest safety study, covering 435 patients on doses of 5 mg or less, found three main side effects.
- Excess body hair (hypertrichosis): The most common side effect by far, occurring in about 55% of patients. The same follicle-stimulating mechanism that regrows scalp hair also affects hair on the face, arms, and elsewhere. This was more common at higher doses and was the primary reason some patients, particularly women, discontinued treatment.
- Lower limb swelling: Occurred in about 6% of patients, more frequently in women (9%) than men (3%). This happens because blood vessel dilation can cause fluid to shift into surrounding tissues.
- Heart palpitations: Reported in about 4% of patients. When blood vessels dilate and blood pressure drops slightly, the heart can compensate by beating faster. The general guidance is to monitor your resting pulse and flag any increase of 20 beats per minute or more.
Regular weight monitoring is also recommended, since sudden weight gain can signal fluid retention. These side effects are dose-dependent, which is why the low-dose approach (1 to 5 mg) used for hair loss carries a much milder risk profile than the higher doses used historically for resistant high blood pressure.
Why Some People Respond Better Than Others
Individual variation in sulfotransferase enzyme activity is likely the biggest factor determining how well minoxidil works for any given person. Since at least four different enzymes contribute to converting minoxidil into its active form, your genetic makeup influences how efficiently that conversion happens. People with higher baseline sulfotransferase activity tend to respond better.
The oral route improves the odds by recruiting liver enzymes into the activation process, but it doesn’t eliminate variability entirely. This helps explain why study results show a wide range of responses, from minimal improvement to dramatic regrowth, even at the same dose.